Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan van den Hof

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
Using existing data to illustrate--and close--the gap in access to new anti-tuberculosis drugsCarole Mitnick, Susan van den Hof
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 22, 2015
Elevated mortality after successful tuberculosis treatmentSusan van den Hof, Martien W Borgdorff
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistanceFrank Cobelens, Agnes Gebhard, Susan van den Hof
American Journal of Respiratory and Critical Care Medicine|July 2, 2015
How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?Agnes Gebhard, Susan van den Hof, Frank Cobelens
Infection Control and Hospital Epidemiology|April 28, 2007
Associations between surgical site infection risk and hospital operation volume and surgeon operation volume among hospitals in the Dutch nosocomial infection surveillance networkJan Muilwijk, Susan van den Hof, Jan C Wille
The European Respiratory Journal|May 2, 2020
Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods studyIneke Spruijt, Connie Erkens, Susan van den Hof, et al.
The European Respiratory Journal|September 25, 2021
Tailored approaches facilitate high completion of tuberculosis infection treatment among migrantsIneke Spruijt, Chantal Joren, Susan van den Hof, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 20, 2024
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: Repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022Anne J Huiberts, Susan van den Hof, Mirjam J Knol
Emerging Infectious Diseases|June 18, 2004
Ring vaccination and smallpox controlMirjam Kretzschmar, Susan van den Hof, Jacco Wallinga, et al.
Journal of Advanced Nursing|July 3, 2018
Patient support during treatment for active tuberculosis and for latent tuberculosis infection: Policies and practices in European low-incidence countriesNiesje Jansen-Aaldring, Sarah van de Berg, Susan van den Hof
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
Using existing data to illustrate--and close--the gap in access to new anti-tuberculosis drugsCarole Mitnick, Susan van den Hof
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 22, 2015
Elevated mortality after successful tuberculosis treatmentSusan van den Hof, Martien W Borgdorff
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistanceFrank Cobelens, Agnes Gebhard, Susan van den Hof
American Journal of Respiratory and Critical Care Medicine|July 2, 2015
How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?Agnes Gebhard, Susan van den Hof, Frank Cobelens
Infection Control and Hospital Epidemiology|April 28, 2007
Associations between surgical site infection risk and hospital operation volume and surgeon operation volume among hospitals in the Dutch nosocomial infection surveillance networkJan Muilwijk, Susan van den Hof, Jan C Wille
The European Respiratory Journal|May 2, 2020
Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods studyIneke Spruijt, Connie Erkens, Susan van den Hof, et al.
The European Respiratory Journal|September 25, 2021
Tailored approaches facilitate high completion of tuberculosis infection treatment among migrantsIneke Spruijt, Chantal Joren, Susan van den Hof, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 20, 2024
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: Repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022Anne J Huiberts, Susan van den Hof, Mirjam J Knol
Emerging Infectious Diseases|June 18, 2004
Ring vaccination and smallpox controlMirjam Kretzschmar, Susan van den Hof, Jacco Wallinga, et al.
Journal of Advanced Nursing|July 3, 2018
Patient support during treatment for active tuberculosis and for latent tuberculosis infection: Policies and practices in European low-incidence countriesNiesje Jansen-Aaldring, Sarah van de Berg, Susan van den Hof
Pageof 14